Literature DB >> 5301381

Controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in Calcutta.

A Das Gupta, R Sinha, D L Shrivastava, S P De, B L Taneja, M S Rao, A H Abou-Gareeb.   

Abstract

To assess the effectiveness of cholera vaccines, 2 controlled field trials were made in Calcutta-an endemic area-during 1964 and 1965. Three Indian vaccines of which 1 was grown on casein hydrolysate and 2 on agar, a freeze-dried vaccine from the Walter Reed Army Institute of Research (WRAIR), Washington, D.C., and an El Tor vaccine from the Philippines were used, with typhoid-paratyphoid (TAB) vaccine as a control. The 210 112 volunteers were vaccinated subcutaneously with a single dose of one of the vaccines.In the 1964 trial, the number of bacteriologically confirmed cases was not enough to show statistically significant differences in incidence between the 5 vaccine groups and the control group. However, the WRAIR freeze-dried vaccine protected about 40% of the vaccinees for 6 months after vaccination, although the efficacy was higher (57%) during the first 3 months than during the subsequent 3 months (28%). Agar-grown vaccine, produced by the Central Research Institute, Kasauli, was 37% efficacious.In the 1965 trial, owing to the small number of cases in the study area, the Kasauli vaccine was the only one to show statistically significant protection (40%).

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5301381      PMCID: PMC2554277     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  SOME OBSERVATIONS ON GENERAL PRACTICE.

Authors:  W ESSIGMAN; G DISCOMBE
Journal:  Lancet       Date:  1965-03-06       Impact factor: 79.321

  1 in total
  11 in total

1.  Preparation of cholera vaccines by fluorocarbon extraction of cholera Vibrio suspensions.

Authors:  P L Altieri; S Berman; A Groffinger; J P Lowenthal
Journal:  Infect Immun       Date:  1970-04       Impact factor: 3.441

2.  The control of cholera.

Authors:  A S Benenson
Journal:  Bull N Y Acad Med       Date:  1971-10

3.  Serological response to cholera revaccination in a semi-closed community in Calcutta.

Authors:  R Sinha; B C Deb; R Ganguly; S P De; A H Abou-Gareeb; D L Shrivastava
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies.

Authors:  A S Benenson; P R Joseph; R O Oseasohn
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

5.  Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines.

Authors:  R Ganguly; L W Clem; Z Bencić; R Sinha; R Sakazaki; R H Waldman
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

6.  Attenuated recombinant strains of Vibrio cholerae for oral immunization.

Authors:  B S Srivastava; V B Sinha; R Srivastava
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

7.  Experimental Cholera in Chinchillas: the Immune Response in Serum and Intestinal Secretions to Vibrio cholerae and Cholera Toxin.

Authors:  U Blachman; S R Graboff; G E Haag; E Gottfeld; M J Pickett
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

8.  Flagella-induced immunity against experimental cholera in adult rabbits.

Authors:  R J Yancey; D L Willis; L J Berry
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.

Authors:  A S Benenson; W H Mosley; M Fahimuddin; R O Oseasohn
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

Review 10.  Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected).

Authors:  Patricia M Graves; Jonathan J Deeks; Vittorio Demicheli; Tom Jefferson
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.